Neurooncology: 2025 update by Michel Mittelbronn

Get full text

Park7 deletion leads to sex-specific transcriptome changes involving NRF2-CYP1B1 axis in mouse midbrain astrocytes by Sergio Helgueta, Tony Heurtaux, Alessia Sciortino, Yujuan Gui, Jochen Ohnmacht, Pauline Mencke, Ibrahim Boussaad, Rashi Halder, Pierre Garcia, Rejko Krüger, Michel Mittelbronn, Manuel Buttini, Thomas Sauter, Lasse Sinkkonen

Get full text

AMP-activated protein kinase mediates adaptation of glioblastoma cells to conditions of the tumor microenvironment by Nadja I. Lorenz, Benedikt Sauer, Hans Urban, Jan-Béla Weinem, Bhavesh S. Parmar, Pia S. Zeiner, Maja I. Strecker, Dorothea Schulte, Michel Mittelbronn, Tijna Alekseeva, Lisa Sevenich, Patrick N. Harter, Christian Münch, Joachim P. Steinbach, Anna-Luisa Luger, Dieter Henrik Heiland, Michael W. Ronellenfitsch

Get full text

EGFL7 enhances surface expression of integrin α5β1 to promote angiogenesis in malignant brain tumors by Nevenka Dudvarski Stanković, Frank Bicker, Stefanie Keller, David TW Jones, Patrick N Harter, Arne Kienzle, Clarissa Gillmann, Philipp Arnold, Anna Golebiewska, Olivier Keunen, Alf Giese, Andreas von Deimling, Tobias Bäuerle, Simone P Niclou, Michel Mittelbronn, Weilan Ye, Stefan M Pfister, Mirko HH Schmidt

Get full text

Endothelial cell‐derived angiopoietin‐2 is a therapeutic target in treatment‐naive and bevacizumab‐resistant glioblastoma by Alexander Scholz, Patrick N Harter, Sebastian Cremer, Burak H Yalcin, Stefanie Gurnik, Maiko Yamaji, Mariangela Di Tacchio, Kathleen Sommer, Peter Baumgarten, Oliver Bähr, Joachim P Steinbach, Jörg Trojan, Martin Glas, Ulrich Herrlinger, Dietmar Krex, Matthias Meinhardt, Astrid Weyerbrock, Marco Timmer, Roland Goldbrunner, Martina Deckert, Christian Braun, Jens Schittenhelm, Jochen T Frueh, Evelyn Ullrich, Michel Mittelbronn, Karl H Plate, Yvonne Reiss

Get full text